Epigenetic editing in cardiovascular medicine: moving beyond the hype

Luca Chiapperino; Michelle Habets; Francesco Paneni

doi:10.1038/s41569-025-01143-0

Epigenetic editing in cardiovascular medicine: moving beyond the hype

Luca Chiapperino^*, Michelle Habets, Francesco Paneni

^*Corresponding author for this work

Knowledge Technology and Innovation

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Abstract

Epigenetic editing holds great promise for the treatment of many diseases, including cardiovascular disease. However, realizing this potential requires more than developing robust technology and demands a steadfast focus on patient needs and inclusion, to ensure that access to epigenetic medicine will be equitable and will benefit diverse populations worldwide.

Original language	English
Article number	71
Pages (from-to)	389-390
Journal	Nature Reviews Cardiology
Volume	22
Issue number	6
Early online date	28 Feb 2025
DOIs	https://doi.org/10.1038/s41569-025-01143-0
Publication status	Published - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41569-025-01143-0

Cite this

@article{cf06e4f13607448f8ef2445aa3a96622,

title = "Epigenetic editing in cardiovascular medicine: moving beyond the hype",

abstract = "Epigenetic editing holds great promise for the treatment of many diseases, including cardiovascular disease. However, realizing this potential requires more than developing robust technology and demands a steadfast focus on patient needs and inclusion, to ensure that access to epigenetic medicine will be equitable and will benefit diverse populations worldwide.",

author = "Luca Chiapperino and Michelle Habets and Francesco Paneni",

year = "2025",

doi = "10.1038/s41569-025-01143-0",

language = "English",

volume = "22",

pages = "389--390",

journal = "Nature Reviews Cardiology",

issn = "1759-5002",

publisher = "Nature",

number = "6",

}

TY - JOUR

T1 - Epigenetic editing in cardiovascular medicine

T2 - moving beyond the hype

AU - Chiapperino, Luca

AU - Habets, Michelle

AU - Paneni, Francesco

PY - 2025

Y1 - 2025

N2 - Epigenetic editing holds great promise for the treatment of many diseases, including cardiovascular disease. However, realizing this potential requires more than developing robust technology and demands a steadfast focus on patient needs and inclusion, to ensure that access to epigenetic medicine will be equitable and will benefit diverse populations worldwide.

AB - Epigenetic editing holds great promise for the treatment of many diseases, including cardiovascular disease. However, realizing this potential requires more than developing robust technology and demands a steadfast focus on patient needs and inclusion, to ensure that access to epigenetic medicine will be equitable and will benefit diverse populations worldwide.

U2 - 10.1038/s41569-025-01143-0

DO - 10.1038/s41569-025-01143-0

M3 - Comment/Letter to the editor

C2 - 40021936

AN - SCOPUS:86000054864

SN - 1759-5002

VL - 22

SP - 389

EP - 390

JO - Nature Reviews Cardiology

JF - Nature Reviews Cardiology

IS - 6

M1 - 71

ER -

Epigenetic editing in cardiovascular medicine: moving beyond the hype

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this